Changzhou Qianhong Biopharma CO.,LTD (SHE:002550)

SHE:002550 Revenue

Changzhou Qianhong Biopharma CO.,LTD had revenue of 400.29M CNY in the quarter ending June 30, 2026, a decrease of -2.58%. This brings the company's total for the last twelve months to 1.47B, down -4.21% year-over-year. In the year 2025, Changzhou Qianhong Biopharma CO.,LTD had annual revenue of 1.57B with 2.95% growth. That makes Changzhou Qianhong Biopharma CO.,LTD the 16,776th largest company in the world by revenue and 3,029th in China.

• Revenue (ttm): 1.47B
• Revenue Growth: -4.21%
• P/S Ratio: 5.26
• Revenue / Employee: 1.41M
• Employees: 1,038
• Market Cap: 7.84B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Biomedicine 1.53B 97.5%
• Others 39.50M 2.5%

By Geography

Chart

• China 1.21B 76.9%
• Overseas 362.85M 23.1%

Fiscal year ended Dec 31, 2025 See the full SHE:002550 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.57B	45.03M	2.95%
Dec 31, 2024	1.53B	-288.03M	-15.88%
Dec 31, 2023	1.81B	-489.28M	-21.24%
Jan 1, 2023	2.30B	428.61M	22.86%
Jan 1, 2022	1.87B	207.33M	12.43%

Data Source: S&P Global Market Intelligence Last updated: Aug 7, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 20, 2026

Data Sources Report a data error